Table 1 Patient baseline characteristics
Variables | Baseline phase (n=106) | IPA implementation phase (n=104) | p value |
|---|---|---|---|
Age; median (IQR), years | 50.0 (39) | 57.5 (38) | 0.166* |
Female sex, % | 57.5 | 66.3 | 0.189† |
Initial nausea score; median (IQR), VAS | 6 (3) | 7 (3) | 0.208* |
Initial pain score; median (IQR), VAS | 5 (6) | 5 (4) | 0.977* |
Presumed nausea cause upon ED presentation | 0.079† | ||
Medication side effect; n (%) | 7 (6.6) | 7 (6.7) | |
Abdominal pathology; n (%) | 52 (49.1) | 53 (51.0) | |
Headache; n (%) | 10 (9.4) | 16 (15.4) | |
Vertigo; n (%) | 4 (3.8) | 10 (9.6) | |
Other; n (%) | 33 (31.1) | 18 (17.3) | |